Philadelphia, PA, Oct. 22, 2025 (GLOBE NEWSWIRE) — The Option Sellers School (OSS), founded by seasoned options trader and educator Peter Pru, has just launched and it's quickly gaining traction among everyday investors seeking a simpler, more transparent path to income generation. The platform's flagship curriculum, the Ark Options Strategy, draws on more than a […]
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=173518&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
Peter Pru Launches Option Sellers School and the Ark Options Strategy to Redefine Options Education for Everyday Investors A transparent, education-first approach helping busy professionals generate consistent income without day trading. GlobeNewswire October 23, 2025 Philadelphia, PA, Oct. 22, 2025 (GLOBE NEWSWIRE) — The Option Sellers School (OSS), founded by seasoned options trader and educator
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD) (OTCQB: DVHGF), a biopharmaceutical corporation specializing in the development of prescription drugs targeting inflammatory diseases today announced that Dr. André Boulet, PhD, Chairman and Chief Executive Officer, will present at
HarbourBioMed (HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced positive Phase II clinical data for porustobart (HBM4003), a next-generation, fully human heavy-chain-only anti-CTLA-4 antibody, in combination with tislelizumab, in patients with microsatellite stable (MSS) metastatic colorectal cancer (mCRC). https://mma.prnewswire.com/media/1096360/HB_for_email_Logo.jpg The multicenter,
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / If you suffered a loss on your investment in Savara Inc. ("Savara" or the "Company") (NASDAQ:SVRA), contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities
(NASDAQ:HCM),(LSE – AIM:HCM),(HKSE:0013), — First investigational drug candidate using the HUTCHMED ATTC technology platform to create potent targeted therapy payloads while mitigating related toxicities — — Unique, highly potent PI3K/PIKK inhibitor payload optimized to exploit antibody-conjugate advantages, with directed delivery and low plasma exposure of free payload — — Preclinical data shows robust antitumor activity
HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics GlobeNewswire October 23, 2025 — First investigational drug candidate using the HUTCHMED ATTC technology platform to create potent targeted therapy payloads while mitigating related toxicities — — Unique, highly potent PI3K/PIKK inhibitor payload optimized to exploit antibody-conjugate advantages, with
Ornn Compute Exchange and Hydra Host have announced a strategic partnership to advance thefinancialization of compute resources and bring greater transparency to GPU prices. The collaboration integrates Hydra Host's real-time infrastructure data and 30,000+GPUs under management with Ornn's compute price indices and market analytics. https://mma.prnewswire.com/media/2803263/Ornn_Compute_Logo.jpg According to Hydra Capital Managing Director Kai Golden, “Compute is
In the news release, Historic Human Rights Verdict: Jury Awards $20M+ To Sudanese Refugees In Landmark Genocide Litigation, issued 17-Oct-2025 by DiCello Levitt LLP over PR Newswire, we are advised by the company of numerical updates in the first and second paragraphs. The complete, corrected release follows: Historic Human Rights Verdict: Jury Awards $20M+ To